A lawsuit filed… and then rejected less than 24 hours later.In this episode of Trade To Black, presented by Flowhub, host Shadd Dales and Anthony Varrell break down one of the more surprising developments out of Washington this week. After Smart Approaches to Marijuana (SAM) moved to block the Trump administration’s Medicare coverage pilot for hemp-derived CBD and low-dose THC products, a federal judge quickly denied the request — keeping the program alive and setting a hearing date for 4/20.This isn’t just a legal headline — it’s a signal.Because it shows how quickly the conversation around cannabinoids and federal healthcare is evolving. And it raises a bigger question: is policy starting to move faster than the opposition can react?We also shift to Michigan, where a sheriff running for governor is pledging to repeal the state’s marijuana tax increase — another example of how cannabis policy is becoming a central political issue at the state level.In the second segment, Hugo Alves, CEO of Auxly Cannabis Group (TSX: XLY) (OTCQB: CBWTF), joins the show to break down a strong 2025 earnings performance. The company reported record revenue of $151.5 million, a 24% increase year-over-year, alongside a 29% adjusted EBITDA margin — standing out in a Canadian market still facing pricing pressure and margin compression.From policy to performance — we got you covered. Log on and leave your comments!#CannabisNews #CannabisPolicy #CBD #CannabisStocks #Auxly #CannabisInvesting #TDR #CannabisIndustry #MSOS #CannabisEarningsWant to see more Cannabis Reform videos?🎬    • SAM Lawsuit Targets CBD Medicare Program |...  🎬    • White House Meetings Signal New CBD Rules ...  🎬    • Congressman Pressures DOJ on Cannabis Resc...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

A new lawsuit in Washington is putting a spotlight on where cannabis, healthcare, and federal policy are all starting to collide.In this episode of TDR Cannabis in 5, presented by FRE Nicotine Pouches, Shadd Dales breaks down a legal challenge filed by Smart Approaches to Marijuana (SAM), aimed at blocking the Trump administration’s proposed Medicare pilot program for hemp-derived CBD and low-dose THC products.At its core, this isn’t just a policy disagreement — it’s a fight over timing and authority.The administration has been working toward a structured program that would allow Medicare recipients to access cannabinoid-based products under a controlled benefit model. The goal is to introduce oversight and guardrails to a category that already exists at scale across the U.S.But SAM is pushing back, arguing that the federal government is moving too quickly — especially while cannabis still sits in a complicated regulatory position.What makes this more significant is the timing.With cannabis rescheduling still in progress, this lawsuit raises a broader question: should federal healthcare programs move forward before a clear regulatory framework is fully in place?For investors and operators, this isn’t about immediate impact — it’s about signals.Legal challenges like this often emerge when policy momentum is building, and they can either slow progress or force clarity.Either way, this is another sign that cannabinoids are moving deeper into the federal healthcare conversation.If you’re looking for a cleaner way to stay focused throughout your day, check out FRE Nicotine Pouches. No smoke, no vapor — just a discreet way to stay sharp when it matters most.👉 Visit frepouch.com and use promo code TDR20 to save $20 on your first order.#CannabisPolicy #CannabisNews #CBD #Medicare #CannabisRescheduling #DOJ #FDA #CannabisIndustry #TDR #CannabisInvestingWant to see more Cannabis Reform videos?🎬    • White House Meetings Signal New CBD Rules ...  🎬    • Congressman Pressures DOJ on Cannabis Resc...  🎬    • CLIMB Act Could Change Cannabis Forever | ...  🎬    • Medicare CBD Program Raises Questions In W...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

White House meetings… FDA policy… and cannabis rescheduling all happening at the same time.In this episode of TDR Cannabis in 5, presented by Flowhub, Shadd Dales breaks down a developing story out of Washington that the entire cannabis industry is watching closely.According to new reporting, the Office of Management and Budget is hosting a series of high-level meetings with cannabis operators, hemp stakeholders, and industry groups. At the center of these discussions is a long-awaited FDA enforcement framework for CBD — an issue that has remained unresolved since the 2018 Farm Bill.While the focus appears to be on CBD, the broader implication is much bigger.These meetings are part of the formal rulemaking process, signaling that federal agencies are actively aligning on cannabis-related policy. And that matters — especially as the industry continues to wait on a final decision regarding cannabis rescheduling.For years, the lack of clear CBD regulation has allowed a massive, largely unregulated market to develop, including the rise of intoxicating hemp-derived THC products. Now, with growing pressure in Washington to address that issue, these meetings could shape future enforcement, product availability, and the competitive landscape across the sector.Individually, these are incremental steps.But together, they point toward a coordinated federal approach to cannabis regulation — something the market has been waiting for.#CannabisNews #CBD #CannabisPolicy #FDA #DOJ #CannabisRescheduling #HempIndustry #CannabisIndustry #TDR #CannabisInvestingWant to see more Cannabis Reform videos?🎬    • Congressman Pressures DOJ on Cannabis Resc...  🎬    • CLIMB Act Could Change Cannabis Forever | ...  🎬    • Medicare CBD Program Raises Questions In W...  🎬    • Does Cannabis Rescheduling Actually Unlock...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

New York is marking five years of legalization with more than $3.3 billion in total cannabis sales, while pressure continues to build across the U.S.—from Congress demanding answers on rescheduling to new signals out of Indiana that the debate is far from settled.In this episode of Trade To Black presented by Flowhub, host Shadd Dales and Anthony Varrell walk through the latest developments shaping the cannabis industry.Segment one begins in New York as the state hits a major milestone, reinforcing its position as one of the largest regulated markets in the country. The focus then shifts to Washington, where Congressman Steve Cohen is pressing the DOJ for an update on cannabis rescheduling—now months removed from President Trump’s executive order directing the process forward.Segment two features Michael Bronstein, President of the American Trade Association for Cannabis and Hemp (ATACH), providing policy insight on what’s unfolding at both the federal and state level.That includes Indiana, where Governor Mike Braun is now openly acknowledging that legalization pressure is rising. He points to widespread use, surrounding legal states, and shifting views among law enforcement—even as legislative leadership remains opposed for now.With federal rescheduling still in motion and state-level dynamics continuing to evolve, the broader direction is becoming clearer.The takeaway—pressure is building, and the tone is starting to change.#CannabisNews #CannabisReform #MarijuanaPolicy #CannabisIndustry #CannabisLegalization #USCannabis #NewYorkCannabis #IndianaCannabis #CannabisStocks #TradeToBlackWant to see last week's recap?🎬    • Cannabis Stocks React to Policy Uncertaint...  Want to see more Cannabis Reform videos?🎬    • Congressman Pressures DOJ on Cannabis Resc...  🎬    • CLIMB Act Could Change Cannabis Forever | ...  🎬    • Medicare CBD Program Raises Questions In W...  🎬    • Does Cannabis Rescheduling Actually Unlock...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

In a market where everything feels red… the ETF landscape is telling a clearer story.In today’s episode of TDR Cannabis in 5, presented by Flowhub, we step back from individual stocks and look at how cannabis ETFs have actually performed over the same timeframe — from late August through today.And the reality is pretty straightforward.AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS) is down over 51 percent. ETFMG Alternative Harvest ETF (NYSEARCA: MJ) is down nearly 48 percent. Amplify Seymour Cannabis ETF (NYSEARCA: CNBS) is down more than 63 percent. Even broader exposure vehicles like Cambria Cannabis ETF (BATS: TOKE) are shutting down altogether.But within that same environment, one ETF has held up better than the rest.AdvisorShares Pure Cannabis ETF (NYSEARCA: YOLO).Not because it’s been strong — but because it’s been less weak.That difference comes down to structure. YOLO isn’t fully tied to U.S. multi-state operators. Instead, it includes names like Village Farms International (NASDAQ: VFF), High Tide Inc. (NASDAQ: HITI) (TSXV: HITI), Cronos Group (NASDAQ: CRON) (TSX: CRON), Charlotte’s Web Holdings (TSX: CWEB) (OTCQX: CWBHF), and Organigram Holdings (NASDAQ: OGI) (TSX: OGI).And in this kind of market, diversification has mattered.This isn’t a strong market — but it’s a selective one. And right now, that distinction is starting to show.#CannabisStocks #CannabisETF #MSOS #YOLOETF #CannabisInvesting #CannabisMarket #CannabisNews #TDR #StockMarket #ETFInvestingWant to see last week's recap?🎬    • Cannabis Stocks React to Policy Uncertaint...  Want to see more Cannabis Reform videos?🎬    • Congressman Pressures DOJ on Cannabis Resc...  🎬    • CLIMB Act Could Change Cannabis Forever | ...  🎬    • Medicare CBD Program Raises Questions In W...  🎬    • Does Cannabis Rescheduling Actually Unlock...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

Three months later… and still no update.In today’s episode of TDR Cannabis in 5, presented by Flowhub, we break down the growing pressure on the Department of Justice as delays continue around federal cannabis rescheduling.Back on December 18th, President Donald Trump signed an executive order directing the DOJ to move cannabis from Schedule I to Schedule III. At the time, markets reacted quickly — with expectations that this would move fast.But here we are now… and nothing has changed.According to new reporting from Marijuana Moment, Congressman Steve Cohen is now demanding answers from Attorney General Pam Bondi and the DEA, asking a simple question: where is the timeline?This isn’t just about politics — it’s about execution.Because while the executive order created momentum, the actual rescheduling process still requires a formal rulemaking process. And right now, that process appears stalled.We also get into a key issue that’s flying under the radar — the DOJ missing a federal deadline tied to cannabis research reform, which only adds more pressure to an already delayed process.For investors, this matters.The market priced in speed… and now it’s dealing with uncertainty.Until a final rule is published, cannabis remains a Schedule I substance — and that means no real change yet.00:04:50 — Key Takeaways Ahead#CannabisIndustry #CannabisRescheduling #DOJ #DEA #CannabisStocks #CannabisNews #FederalReform #Schedule3 #TDR #CannabisInvestingWant to see more Cannabis Reform videos?🎬    • CLIMB Act Could Change Cannabis Forever | ...  🎬    • Medicare CBD Program Raises Questions In W...  🎬    • Does Cannabis Rescheduling Actually Unlock...  🎬    • Texas Hemp Ban Creates Winners And Losers ...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

A federal bill that’s getting very little attention right now… but could completely change the financial structure of the U.S. cannabis industry.Today we’re breaking down the CLIMB Act — and why this goes way beyond banking. This isn’t just about access to financial services… it’s about unlocking capital, institutional investment, and potentially allowing U.S. cannabis companies to list on major exchanges like the NYSE and NASDAQ.TDR Cannabis in 5 presented by FRE Nicotine Pouches, hosted by Shadd Dales, takes a closer look at what the CLIMB Act actually does, why it matters for MSOs, and how it compares to SAFE Banking. From safe harbor protections to SBA loan access and investor protections, this bill could level the playing field between U.S. and Canadian operators.The reality is simple — without capital, the industry can’t scale. And while the market continues to focus on rescheduling, legislation like this could have a far more direct impact on valuations, liquidity, and long-term growth.If this moves forward, it’s not just incremental change — it’s structural.#CannabisIndustry #CLIMBAct #CannabisStocks #MSOS #CannabisInvesting #SAFEbanking #CannabisNews #NYSE #NASDAQ #CannabisReschedulingWant to see more Cannabis Reform videos?🎬    • Medicare CBD Program Raises Questions In W...  🎬    • Does Cannabis Rescheduling Actually Unlock...  🎬    • Texas Hemp Ban Creates Winners And Losers ...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

In this episode of Trade To Black, presented by Flowhub, hosts Shadd Dales and Anthony Varrell cover three key stories across earnings, hemp policy, and medical cannabis reform.We start with Raj Grover, CEO of High Tide (NASDAQ:HITI), following a strong quarterly report. The company posted record revenue of $178.3 million, improved margins, and continued free cash flow generation. We discuss what’s driving performance, including retail market share gains, Cabana Club growth to over 2.5 million members, and progress internationally in Germany.Then Adam Stettner returns in segment #2 to break down what’s actually happening in Missouri. Despite headlines, there is no official hemp ban. A House bill passed but stalled in the Senate, while regulators continue enforcement actions targeting intoxicating hemp products. The conversation focuses on what operators need to understand right now.We also look at changes in Georgia, where lawmakers are expanding the medical cannabis program. New rules remove THC caps, allow vaporization, and broaden qualifying conditions — a meaningful shift for patient access and market growth.This episode focuses on what’s real, what’s changing, and what matters for investors and operators.#CannabisStocks #HighTide #HempPolicy #GeorgiaCannabis #MissouriHemp #CannabisInvesting #CannabisNews #RajGrover #AdamStettner #CannabisIndustry #CannabisNewsWant to see more Cannabis Reform videos?🎬    • Medicare CBD Program Raises Questions In W...  🎬    • Does Cannabis Rescheduling Actually Unlock...  🎬    • Texas Hemp Ban Creates Winners And Losers ...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

This is one of those stories that might not grab headlines right away… but probably should.In today’s episode, we’re breaking down a major milestone from Avicanna (TSX: AVCN), as their subsidiary SMGH completes its first commercial export of organic, CBG-dominant cannabis flower to Australia — one of the most tightly regulated medical markets in the world.On the surface, it’s an export story.But when you step back… it’s really about something bigger.For years, the industry has talked about whether cannabis can be grown more efficiently outside of North America — lower cost, better climate, scalable production. A lot of companies tried. Most didn’t make it.Now we’re starting to see what execution actually looks like.In this conversation, we get into:

• Why this export matters more than people think
• How Colombia is positioning itself in the global supply chain
• The role of organic cultivation and cost advantages
• And what this could mean for international medical markets moving forward

If you’re looking at where cannabis is heading over the next 3–5 years — especially from a global and supply chain perspective — this is one to pay attention to.#Avicanna #CannabisIndustry #MedicalCannabis #CannabisExports #CannabisInvesting #GlobalCannabis #CannabisStocks #CBG #CannabisNews #CannabisMarketWant to see more Cannabis Reform videos?🎬    • Medicare CBD Program Raises Questions In W...  🎬    • Does Cannabis Rescheduling Actually Unlock...  🎬    • Texas Hemp Ban Creates Winners And Losers ...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

In this episode of Trade To Black, presented by Flowhub, hosts Shadd Dales and Anthony Varrell break down the new Medicare CBD pilot program — and why it could end up being one of the more important federal developments we’ve seen in years.For the first time, the U.S. government is testing a structured model where Medicare patients can receive a $500 annual benefit card to purchase qualifying hemp-derived CBD products. This is tied directly to the 2027 Medicare rule — so this isn’t theoretical, it’s a real pilot that’s been put in motion.To help make sense of it, Dr. Leigh Vinocur joins the show — one of the leading cannabis physicians in the country and a member of the National Cannabis Care Council (NCCC). This isn’t just a surface-level conversation — we get into how this actually works for patients, what kind of physician oversight is involved, and what CMS is ultimately trying to measure through this program.But the bigger question is this:Is this just a contained pilot… or an early step toward cannabinoids being integrated into the U.S. healthcare system?Because if this expands beyond 2027 — the implications for companies, investors, and policy are significant.#CannabisIndustry #CBD #Medicare #CannabisPolicy #Hemp #CannabisInvesting #HealthcareInnovation #CannabisStocks #Regulation #TDRWant to see more Cannabis Reform videos?🎬    • Hemp THC Drinks Shift Toward Federal Regul...  🎬    • Medicare CBD Program Raises Questions In W...  🎬    • Does Cannabis Rescheduling Actually Unlock...  🎬    • Texas Hemp Ban Creates Winners And Losers ...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...